Pituitary apoplexy due to thyroxine therapy in a patient with congenital hypothyroidism
dc.authorscopusid | 8678198300 | |
dc.authorscopusid | 35387601800 | |
dc.authorscopusid | 35489765100 | |
dc.authorscopusid | 16231562400 | |
dc.authorscopusid | 16021207900 | |
dc.authorscopusid | 15921923000 | |
dc.authorscopusid | 23994048900 | |
dc.contributor.author | Tutanc, Murat | |
dc.contributor.author | Altas, Murat | |
dc.contributor.author | Yengil, Erhan | |
dc.contributor.author | Ustun, Ihsan | |
dc.contributor.author | Dolapcioglu, Kenan S. | |
dc.contributor.author | Balci, Ali | |
dc.contributor.author | Sefil, Fatih | |
dc.date.accessioned | 2024-09-19T15:49:47Z | |
dc.date.available | 2024-09-19T15:49:47Z | |
dc.date.issued | 2013 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | A 24-year-old woman was admitted with general weakness, umbilical swelling, developmental delay, speech disorder, constipation, gait problem. Her findings were umbilical hernia, xerosis, dry hair, and short stature. After thyroxine treatment, she also had headache, vomiting, and palpitation, lack of appetite, and sleep disturbance. Pituitary magnetic resonance imaging revealed a heterogeneous mass at the central part of the gland on coronal section and it was interpreted as pituitary apoplexy. In the current case, the patient with congenital hypothyroidism (CH) developed pituitary apoplexy (PA) after thyroxine therapy. Therefore, it is suggested that the complaints were related to PA rather than adrenal insufficiency. Here we describe a case report evaluating PA in a patient with thyrotrophic pituitary adenoma due to CH. To the best of our knowledge, this is the first case in terms of PA associated with CH after thyroxine therapy in the literature. | en_US |
dc.identifier.endpage | 311 | en_US |
dc.identifier.issn | 0125-9326 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 24448336 | en_US |
dc.identifier.scopus | 2-s2.0-84921024999 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 306 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/15410 | |
dc.identifier.volume | 45 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Acta medica Indonesiana | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Adult | en_US |
dc.subject | Congenital Hypothyroidism | en_US |
dc.subject | Diagnosis, Differential | en_US |
dc.subject | Disease Management | en_US |
dc.subject | Female | en_US |
dc.subject | Glucocorticoids | en_US |
dc.subject | Hormone Replacement Therapy | en_US |
dc.subject | Humans | en_US |
dc.subject | Magnetic Resonance Imaging | en_US |
dc.subject | Pituitary Apoplexy | en_US |
dc.subject | Pituitary Gland | en_US |
dc.subject | Pituitary Neoplasms | en_US |
dc.subject | Thyroxine | en_US |
dc.subject | Treatment Outcome | en_US |
dc.subject | Withholding Treatment | en_US |
dc.subject | glucocorticoid | en_US |
dc.subject | thyroxine | en_US |
dc.subject | adult | en_US |
dc.subject | case report | en_US |
dc.subject | chemically induced | en_US |
dc.subject | congenital hypothyroidism | en_US |
dc.subject | differential diagnosis | en_US |
dc.subject | disease management | en_US |
dc.subject | female | en_US |
dc.subject | hormone substitution | en_US |
dc.subject | human | en_US |
dc.subject | hypophysis | en_US |
dc.subject | nuclear magnetic resonance imaging | en_US |
dc.subject | pathology | en_US |
dc.subject | pathophysiology | en_US |
dc.subject | Pituitary Apoplexy | en_US |
dc.subject | Pituitary Neoplasms | en_US |
dc.subject | treatment outcome | en_US |
dc.subject | treatment withdrawal | en_US |
dc.title | Pituitary apoplexy due to thyroxine therapy in a patient with congenital hypothyroidism | en_US |
dc.type | Article | en_US |